Doctor profile · Federal record
Dr. Vinod Kondragunta
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Austin, TX
- NPI 1588906168
- Accepts Medicare
- 13 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
500 Canyon Ridge Dr Ste 208
Austin, TX 787531632
(512) 654-7800 - Mailing address
-
Po Box 844658
Dallas, TX 752844658
Credentials & registration
- NPI registered
- March 2013 — 13 yrs on file
- Profile last updated
- January 6, 2026
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Texas #W0942
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588906168. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
467
Distinct HCPCS
5
Medicare allowed
$43,670
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 245 | 97 | $102 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 162 | 111 | $69 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 31 | 25 | $132 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 18 | 18 | $141 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 11 | 11 | $91 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 1,180. This provider delivers 0.4× the peer median.Open Payments
Industry payments received
All-time total
$1,259
Transactions
52
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $244.52 | |
| Gilead Sciences, Inc. | 8 | $155.06 | |
| PFIZER INC. | 5 | $120.71 | |
| AstraZeneca Pharmaceuticals LP | 4 | $91.95 | |
| Celgene Corporation | 4 | $89.56 | |
| Daiichi Sankyo Inc. | 3 | $85.30 | |
| Merck Sharp & Dohme LLC | 4 | $84.29 | |
| Ipsen Biopharmaceuticals, Inc | 2 | $70.89 | |
| Incyte Corporation | 3 | $61.54 | |
| TerSera Therapeutics LLC | 2 | $58.28 | |
| EMD Serono, Inc. | 2 | $49.04 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31.35 | |
| ABBVIE INC. | 1 | $28.99 | |
| JAZZ PHARMACEUTICALS INC. | 1 | $26.97 | |
| Tempus AI, Inc | 1 | $20.66 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
421
Patients
118
Total drug cost
$850,687
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 62 | 24 | $1,319 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 47 | 27 | $1,133 |
| Prednisone | Generic | 46 | 14 | $248 |
| Xarelto (Rivaroxaban) | Brand | 33 | 12 | $29,489 |
| Revlimid (Lenalidomide) | Brand | 30 | 0 | $701,951 |
| Eliquis (Apixaban) | Brand | 26 | 13 | $20,898 |
| Ondansetron Hcl | Generic | 26 | 17 | $559 |
| Letrozole | Generic | 24 | 11 | $779 |
| Hydroxyurea | Generic | 23 | 0 | $1,593 |
| Acyclovir | Generic | 22 | 0 | $350 |
Hospital affiliations
Frequently asked questions
What is Dr. Vinod Kondragunta's medical specialty?
Dr. Vinod Kondragunta practices Hematology & Oncology Physician in Austin, TX.
Where does Dr. Vinod Kondragunta practice?
Dr. Vinod Kondragunta practices at 500 Canyon Ridge Dr Ste 208, Austin, TX 787531632. Office phone: 5126547800.
What is Dr. Vinod Kondragunta's NPI?
Dr. Vinod Kondragunta's National Provider Identifier (NPI) is 1588906168, issued by NPPES.
Does Dr. Vinod Kondragunta accept Medicare assignment?
Yes. Dr. Vinod Kondragunta accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Vinod Kondragunta commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.